83-2272-64 ［受注停止］KRIBIOLISA Vixtimotamab ELISA 1 x 96 wells KBI1774
[KRISHGEN BioSystems]
特徴
- Description：ELISA for the detection of bispecific antibody Vixtimotamab in human serum and plasma.
- Lead time for this kit is 5 weeks.
- About the kit： - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity.
- - Recovery rates are between 85 - 115％ - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life： 1 year.Vixtimotamab is a bivalent, bispecific T cell engager （BiTE） antibody targeting CD33 and CD3, being investigated as a combination therapy in patients with relapsed or refractory acute myeloid leukemia （AML）.
仕様
- サイズ：1 x 96 wells
- Reactivity：Human
- アプリケーション：ELISA,Immunoassay
- Sensitivity：Please refer to the current IFU for the updated calibrator range and sensitivity.
- Calibration Range：0 ug/ml - 100 ug/ml
- サンプルタイプ：Human serum and plasma
- 測定方法：Colorimetric, 450nm
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
よくあるご質問（FAQ）
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|